Patents
Patents for C07C 255 - Carboxylic acid nitriles (27,066)
01/2006
01/25/2006EP1618087A2 Antibacterial agents
01/25/2006EP1446224B1 Aromatic compounds containing nitrogen and p-functionalized amines, the production thereof and their use in catalytic reactions
01/25/2006EP1097158B1 Ligands for metals and metal-catalyzed processes
01/25/2006CN1726603A Charge transport compositions and electronic devices made with such compositions
01/25/2006CN1726185A Formulations comprising selective androgen receptor modulators and using method thereof
01/25/2006CN1238337C Pesticide
01/25/2006CN1238334C Improved method for simultaneous preparation of 6-aminocapronitrile and hexamethylene diamine
01/24/2006US6989460 Methods for producing unsaturated carboxylic acids and unsaturated nitriles
01/24/2006CA2255824C Nitrate esters and their use for neurological conditions
01/24/2006CA2176706C Carbonyl containing compounds
01/19/2006WO2006005909A1 Substituted acids for the treatment of respiratory diseases
01/19/2006US20060014831 e.g. 2-[(2-methoxyphenyl)(1-naphthyl)methyl]malononitrile; antiinflammatory and hypoglycemic agent; rheumatoid arthritis, osteoarthritis, psoriatic and juvenile arthritis, inflammatory bowel disease, Crohn's disease, ulcerative and indeterminate colitis, psoriasis, asthma, hyperlipidemia
01/19/2006US20060014806 Dihalo-allyloxy-phenol derivatives having pesticidal activity
01/19/2006US20060014743 Methods of preventing bacterial infections with florfenicol-type antibiotics
01/19/2006US20060014739 Androgen receptor modulators and method of treating disease using the same
01/19/2006DE19755509B4 Cyclobutanon-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung flüssigkristalliner Verbindungen Cyclobutanone derivatives, processes for their preparation and their use for the preparation of liquid crystalline compounds
01/18/2006EP1615877A1 Process for preparing 4-chloro-3-hydroxybutanoic acid ester
01/18/2006CN1723207A Inhibitors of histone deacetylase
01/18/2006CN1723083A Mixed oxide catalyst of rb, ce, cr, ni, fe, bi and mo for the manufacture of acrylonitrile
01/18/2006CN1237048C Method for distilling separating mixture mainly containing 6-amino cyanide and 1,6-dexanediamine
01/17/2006US6987112 Organic compound having cyano group and insecticides/miticides
01/17/2006CA2334713C Therapeutic biaryl derivatives
01/12/2006WO2006003923A1 Substituted benzene compound
01/12/2006WO2006003501A1 Process for preparing synthetic intermediates useful in preparing pyrazole compounds
01/12/2006WO2005094810A3 Novel pharmaceutical compositions
01/12/2006WO2005003063A3 Process for removal of acrolein from acrylonitrile product streams
01/12/2006US20060009651 Benzophenones as inhibitors of reverse transcriptase
01/12/2006CA2572117A1 Process for preparing synthetic intermediates useful in preparing pyrazole compounds
01/11/2006EP1613574A1 Method for the production of at least one partial oxidation and/or ammoxidation product of a hydrocarbon
01/11/2006EP1385814A4 Enantiomerically selective cyclopropanation
01/11/2006CN1720221A Process for the preparation of phenylmalonic acid dinitriles
01/11/2006CN1720220A Method for inhibiting polymerization during the recovery and purification of unsaturated mononitriles
01/11/2006CN1720099A Mixed oxide catalyst of K, Cs, Ce, Cr, Co, Ni, Fe, Bi and Mo for the manufacture of acrylonitrile
01/11/2006CN1718569A Method of preparing ethylenediamine tetracetonitrile and ethylenediamine tetraacetic acid using hydroxy acetonitrile as raw material
01/11/2006CN1235870C Novel use of phenyl hetero alkylamine derivatives
01/11/2006CN1235867C Method for preparing aromatics
01/10/2006US6984754 Aliphatic amino carboxylic and amino phosphonic acids amino nitriles and amino tetrazoles as cellular rescue agents
01/10/2006US6984750 Providing a catalyst support; vapor depositing layers comprising molybdenum, vanadium and tellurium and layer comprising at least one other element; calcining
01/10/2006US6984749 Method for inhibiting polymerization during the recovery and purification of unsaturated mononitriles
01/10/2006US6984645 Aryl carboxylic acids and tetrazoles for treating diabetes, especially type II diabetes
01/10/2006US6984604 Supported bis(phosphorus) ligands and their use in the catalysis
01/10/2006CA2396090C Asymmetric synthesis of pregabalin
01/10/2006CA2299760C Cyano containing oxamic acids and derivatives as thyroid receptor ligands
01/05/2006WO2006002341A2 Methods for purification of trimetallic nitride endohedral metallofullerenes and related fullerene derivatives
01/05/2006WO2006000324A2 New mao-b inhibitors
01/05/2006US20060004093 obesity; antidiabetic agents; Alzheimer's disease; Huntington's disease;schizophrenia; anticancer agents; psoriasis; antiepileptic agents; strokes
01/05/2006US20060004092 e.g. 2-(tert-butoxycarbonylmethyl)-2-allylmalononitrile; pesticidal activity and can control effectively pests such as insect pests, acarine pests, nematode pests
01/05/2006US20060004091 Alpha-phenoxy- or phenylthio-alkanoic acid derivatives in which the phenyl ring is substituted with an acetylene group, e.g., 2-methyl-2-{2-methyl-4-[4-(4-trifluoromethyl-phenyl)-but-3-ynylsulfanyl]-phenoxy}-propionic acid; PPAR delta and/or PPAR alpha agonists used to treat diabetes
01/05/2006US20060002869 E.g., 3-((2E)-2-cyano-3,3-diphenylprop-2-enoyloxy)-2,2-dimethylpropyl 4-((2Z)-2-cyano-3,3-diphenylprop-2-enoyloxy)-2,2-dimethylbutyl (2E)but-2-ene-1,4-dioate); especially for stabilizing dibenzoylmethane sunscreens
01/05/2006CA2571505A1 New mao-b inhibitors
01/05/2006CA2571309A1 Chemical compounds
01/04/2006EP1611145A2 Asymmetric catalysts prepared from optically active bisphosphites bridged by achiral diols
01/04/2006EP1611091A1 Novel compounds
01/04/2006EP1611087A1 Process for recovery of pure acrylonitrile
01/04/2006EP1611086A1 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors
01/04/2006EP1610893A1 System suitable for the hydrocyanation of olefinically unsaturated compounds
01/04/2006CN1714934A Process for preparing catalyst
01/04/2006CN1234685C Method for separation azepine derivative out of mixture contg. amine and azepine derivative
01/04/2006CN1234684C Method for hemihydrogenation of dinitriles in order to form aminonitriles
01/03/2006US6982348 for example, N[(1RS2SR)-2-(4-fluorophenyl)-2-hydroxy-1-[4-fluoromethyl)benzyl]ethyl]-6,7-dihydro-5H-benzo[a]cycloheptene-1-carboxamide; cholesteryl ester transfer protein inhibitory action; lipid-lowering agents
01/03/2006US6982342 Heating using catalyst
01/03/2006US6982335 Synthesis of substituted thiazoline carboxylic acids
01/03/2006US6982263 Peptidyl carbamates; treatments for osteoporosis and autoimmune diseases
12/2005
12/29/2005WO2005123668A1 Glucagon receptor antagonists, preparation and therapeutic uses
12/29/2005WO2005123664A2 Processes for the preparation of 2-cyano-3-naphthalene-1-yl-acrylic acid alkyl or benzyl esters
12/29/2005WO2005123663A1 Processes for the preparation of 2-cyano-3-naphthalene-1-yl-3-phenyl-propionic acid alkyl or benzyl esters
12/29/2005WO2005123662A1 Modified heck reaction
12/29/2005WO2005123661A1 Method for producing nitriles by elimination of water from aldehyde oximes with alkylphosphonic anhydrides
12/29/2005WO2005085189A3 Analogues of congo red and evaluation of their anti-prion activity
12/29/2005WO2005077122A3 Compounds and compositions as lxr modulators
12/29/2005WO2005075412A3 Norbornane based cycloaliphatic compounds containing nitrile groups
12/29/2005US20050288367 Benzyloxy derivatives as MAOB inhibitors
12/29/2005US20050288366 Administering N-(4-carboxybutyl)-N-(p-carboxybenzyl)-benzyl- or phenethyl-amine derivatives: 4-({(4-Carboxybutyl)[3-(4-cyclohexylphenoxy)benzyl]amino}methyl)-benzoic acid; stimulate soluble guanylate cyclase also via a novel mechanism of action which takes place without involvement of the heme group
12/29/2005US20050288282 Anticancer agents; antiproliferative agents
12/29/2005US20050287094 Esters with antimicrobial, bioresistant and fungal resistant properties
12/29/2005DE102005022716A1 Preparation of carbocyclic compounds with five or six benzocondensed rings, useful in liquid crystalline medium, comprises subjecting phenyl derivative to ring closing metathesis reaction in the presence of metathesis catalyst
12/29/2005CA2569459A1 Glucagon receptor antagonists, preparation and therapeutic uses
12/28/2005EP1609778A1 Process for production of 2-cyano-3-hydroxy-n-(4-tri- fluoromethylphenyl)hept-2-en-6-ynamide and process for production of polymorphs thereof
12/28/2005EP1332177A4 Nitrile process
12/28/2005EP0918514B1 Triaryl methane compounds for the treatment of cancer, actinic keratosis and kaposi's sarcoma
12/28/2005CN1714075A Improved process for the preparation of 1,3-substituted indenes
12/28/2005CN1714074A Process for producing aromatic nitrile compound
12/28/2005CN1233623C 2,6-dibromo-4-cyanophenyl ester compounds with herbicidal activity
12/28/2005CN1233622C Process for producing fluorinated dicyanobenzene
12/27/2005US6979746 Organic luminescent material for flat panel displays
12/27/2005CA2305463C Aminobutanoic acid derivatives
12/22/2005WO2005121077A1 Preparation and applications of polymer-supported halogenated benzoquinones as oxidative agents
12/22/2005WO2005121076A1 (diaryl-methyl)-malononitriles and their use as estrogen receptor ligands
12/22/2005WO2005121075A1 Aminoacetonitrile derivatives and their use for controlling parasites on warm-blooded animals
12/22/2005WO2005121069A1 Levodopa prodrugs, and compositions and uses thereof
12/22/2005WO2005121063A1 Process for forming branched composition catalytically by carbon-hydrogen bond activation in a saturated moiety
12/22/2005WO2005063697A3 Substituted n-aryl amidines as selective d1 dopamine receptor antagonists for the treatment of obesity and cns disorders
12/22/2005WO2005061443A3 Benzoyl-substituted phenylalanine amides
12/22/2005US20050283019 selective monoamine oxidase B inhibitors; neurodegenerative diseases; Alzheimer's Disease
12/22/2005US20050282908 Substituted aminopropoxyaryl derivatives useful as agonists for LXR
12/22/2005US20050282891 Parkinson's disease, depression, attention deficit disorder; schizophrenia, manic depression, cognitive impairment disorders, restless legs syndrome, periodic limb movement disorders, Huntington's disease, Tourette's syndrome, congestive heart failure, sustained release
12/22/2005US20050282730 xanthocillin analogues such as 3,3'-Dimethoxyxanthocillin X dimethyl ether, used for increasing platelets in a human having a disease selected from thrombocytopenia caused by bone marrow grafting, surgery, infection, intestinal bleeding, anemia, myelodysplastic syndrome, and thrombopoietin deficiency
12/22/2005CA2568632A1 Levodopa prodrugs, and compositions and uses thereof
12/22/2005CA2566772A1 (diaryl-methyl)-malononitriles and their use as estrogen receptor ligands
12/21/2005EP1606246A1 Method for producing 2-cyan-3-hydroxy-n-(phenyl)but-2-ene amides
1 ... 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 ... 271